New START for Kumar Muthalagappan - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

New START for Kumar Muthalagappan

Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally

  • January 20, 2026

  • 2 min

Share

Original Source(s)

New START for Kumar Muthalagappan

  • January 20, 2026

Related Content

Beyond classical boundaries: rethinking ICU access in acute leukemia

Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments)

Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis